The EMBO Journal
 
Advanced search
Journal home
Current issue
Advance Online Publication
Web Focuses
Archive
Browse by subject
Free online sample issue
Aims and scope
Press releases
ToC by email
Authors & Referees
Guide for authors
Submit an Article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
Subject Categories: Signal Transduction | Cellular Metabolism
The EMBO Journal (2008) 27, 350–360, doi:10.1038/sj.emboj.7601952
Published online 20 December 2007
Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2
EMBO Open
Christian C Witt1, 3, Stephanie H Witt1, 3, Stefanie Lerche1, Dietmar Labeit1, Walter Back2 and Siegfried Labeit1
1 Institute of Anesthesiology and Intensive Care, Universitätsklinikum Mannheim, Mannheim, Germany
2 Institute of Pathology, Universitätsklinikum Mannheim, Mannheim, Germany

To whom correspondence should be addressed
Siegfried Labeit, Institute of Anesthesiology and Intensive Care, University Clinic Mannheim, Theodor-Kutzer-Ufer 1-3, Mannheim 68167, Germany. Tel.: +49 621 383 1626; Fax: +49 621 383 1971; E-mail: siegfried.labeit@anaes.ma.uni-heidelberg.de

3 These authors equally contributed to the work

Received 2 June 2007; Accepted 15 November 2007; Published online 20 December 2007.
Abstract
The muscle-specific RING finger proteins MuRF1 and MuRF2 have been proposed to regulate protein degradation and gene expression in muscle tissues. We have tested the in vivo roles of MuRF1 and MuRF2 for muscle metabolism by using knockout (KO) mouse models. Single MuRF1 and MuRF2 KO mice are healthy and have normal muscles. Double knockout (dKO) mice obtained by the inactivation of all four MuRF1 and MuRF2 alleles developed extreme cardiac and milder skeletal muscle hypertrophy. Muscle hypertrophy in dKO mice was maintained throughout the murine life span and was associated with chronically activated muscle protein synthesis. During ageing (months 4–18), skeletal muscle mass remained stable, whereas body fat content did not increase in dKO mice as compared with wild-type controls. Other catabolic factors such as MAFbox/atrogin1 were expressed at normal levels and did not respond to or prevent muscle hypertrophy in dKO mice. Thus, combined inhibition of MuRF1/MuRF2 could provide a potent strategy to stimulate striated muscles anabolically and to protect muscles from sarcopenia during ageing.
Keywords: muscle hypertrophy and atrophy, striated muscle, ubiquitin ligases MuRF1 and MuRF2, Z-disks
Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2008 by the European Molecular Biology Organization